Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis

被引:152
作者
He, YL
Rajantie, I
Ilmonen, M
Makinen, T
Karkkainen, MJ
Haiko, P
Salven, P
Alitalo, K
机构
[1] Univ Helsinki, Cent Hosp, Biomedicum, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Biomedicum, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Biomedicum, Inst Biomed, FIN-00014 Helsinki, Finland
关键词
D O I
10.1158/0008-5472.CAN-04-0088
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endothelial progenitor cells have been shown to contribute to angiogenesis in various tumor models. Here, we have studied the relative contributions of bone marrow (BM)-derived endothelial progenitors and pre-existing lymphatic vessels to tumor lymphangiogenesis. We did not find significant incorporation of genetically marked BM-derived cells in lymphatic vessels during tumor- or vascular endothelial growth factor C-induced lymphangiogenesis. The degree of tumor lymphangiogenesis correlated with lymphatic vessel density in the peritumoral area, and despite tumor lymphangiogenesis, lymphatic metastasis failed to occur in gene-targeted vascular endothelial growth factor C+/- mice that have hypoplasia of the lymphatic network. Our data demonstrate that during tumor lymphangiogenesis and cancer cell dissemination via the lymphatics, the newly formed lymphatic vessels sprout from the pre-existing local lymphatic network with little if any incorporation of BM-derived endothelial progenitor cells.
引用
收藏
页码:3737 / 3740
页数:4
相关论文
共 23 条
  • [1] Molecular mechanisms of lymphangiogenesis in health and disease
    Alitalo, K
    Carmeliet, P
    [J]. CANCER CELL, 2002, 1 (03) : 219 - 227
  • [2] Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling
    He, YL
    Kozaki, KI
    Karpanen, T
    Koshikawa, K
    Yla-Herttuala, S
    Takahashi, T
    Alitalo, K
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) : 819 - 825
  • [3] A model for gene therapy of human hereditary lymphedema
    Karkkainen, MJ
    Saaristo, A
    Jussila, L
    Karila, KA
    Lawrence, EC
    Pajusola, K
    Bueler, H
    Eichmann, A
    Kauppinen, R
    Kettunen, MI
    Ylä-Herttuala, S
    Finegold, DN
    Ferrell, RE
    Alitalo, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12677 - 12682
  • [4] Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
    Karkkainen, MJ
    Haiko, P
    Sainio, K
    Partanen, J
    Taipale, J
    Petrova, TV
    Jeltsch, M
    Jackson, DG
    Talikka, M
    Rauvala, H
    Betsholtz, C
    Alitalo, K
    [J]. NATURE IMMUNOLOGY, 2004, 5 (01) : 74 - 80
  • [5] Karpanen T, 2001, CANCER RES, V61, P1786
  • [6] Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates
    Kerjaschki, D
    Regele, HM
    Moosberger, I
    Nagy-Bojarski, K
    Watschinger, B
    Soleiman, A
    Birner, P
    Krieger, S
    Hovorka, A
    Silberhumer, G
    Laakkonen, P
    Petrova, T
    Langer, B
    Raab, I
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03): : 603 - 612
  • [7] Krishnan J, 2003, CANCER RES, V63, P713
  • [8] Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
    Lyden, D
    Young, AZ
    Zagzag, D
    Yan, W
    Gerald, W
    O'Reilly, R
    Bader, BL
    Hynes, RO
    Zhuang, Y
    Manova, K
    Benezra, R
    [J]. NATURE, 1999, 401 (6754) : 670 - 677
  • [9] Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
    Lyden, D
    Hattori, K
    Dias, S
    Costa, C
    Blaikie, P
    Butros, L
    Chadburn, A
    Heissig, B
    Marks, W
    Witte, L
    Wu, Y
    Hicklin, D
    Zhu, ZP
    Hackett, NR
    Crystal, RG
    Moore, MAS
    Hajjar, KA
    Manova, K
    Benezra, R
    Rafii, S
    [J]. NATURE MEDICINE, 2001, 7 (11) : 1194 - 1201
  • [10] Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
    Mäkinen, T
    Jussila, L
    Veikkola, T
    Karpanen, T
    Kettunen, MI
    Pulkkanen, KJ
    Kauppinen, R
    Jackson, DG
    Kubo, H
    Nishikawa, SI
    Ylä-Herttuala, S
    Alitalo, K
    [J]. NATURE MEDICINE, 2001, 7 (02) : 199 - 205